Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation

Ryota Usui; Yui Sakuramachi; Yusuke Seino; Kenta Murotani; Hitoshi Kuwata; Hisato Tatsuoka; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino; Daisuke Yabe

doi:10.1111/jdi.12858

Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation

Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe

Endocrinology & Metabolism

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	981-983
Number of pages	3
Journal	Journal of Diabetes Investigation
Volume	9
Issue number	4
DOIs	https://doi.org/10.1111/jdi.12858
Publication status	Published - 07-2018

All Science Journal Classification (ASJC) codes

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1111/jdi.12858

Cite this

Usui, R., Sakuramachi, Y., Seino, Y., Murotani, K., Kuwata, H., Tatsuoka, H., Hamamoto, Y., Kurose, T., Seino, Y., & Yabe, D. (2018). Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation. Journal of Diabetes Investigation, 9(4), 981-983. https://doi.org/10.1111/jdi.12858

Usui, Ryota ; Sakuramachi, Yui ; Seino, Yusuke ; Murotani, Kenta ; Kuwata, Hitoshi ; Tatsuoka, Hisato ; Hamamoto, Yoshiyuki ; Kurose, Takeshi ; Seino, Yutaka ; Yabe, Daisuke. / Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes : The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation. In: Journal of Diabetes Investigation. 2018 ; Vol. 9, No. 4. pp. 981-983.

@article{70ceeceeb2c740e4ac4030c634dd3e81,

title = "Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation",

author = "Ryota Usui and Yui Sakuramachi and Yusuke Seino and Kenta Murotani and Hitoshi Kuwata and Hisato Tatsuoka and Yoshiyuki Hamamoto and Takeshi Kurose and Yutaka Seino and Daisuke Yabe",

year = "2018",

month = jul,

doi = "10.1111/jdi.12858",

language = "English",

volume = "9",

pages = "981--983",

journal = "Journal of Diabetes Investigation",

issn = "2040-1116",

publisher = "Blackwell Publishing Asia Pty Ltd",

number = "4",

}

Usui, R, Sakuramachi, Y, Seino, Y, Murotani, K, Kuwata, H, Tatsuoka, H, Hamamoto, Y, Kurose, T, Seino, Y & Yabe, D 2018, 'Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation', Journal of Diabetes Investigation, vol. 9, no. 4, pp. 981-983. https://doi.org/10.1111/jdi.12858

Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes : The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation. / Usui, Ryota; Sakuramachi, Yui; Seino, Yusuke; Murotani, Kenta; Kuwata, Hitoshi; Tatsuoka, Hisato; Hamamoto, Yoshiyuki; Kurose, Takeshi; Seino, Yutaka; Yabe, Daisuke.

In: Journal of Diabetes Investigation, Vol. 9, No. 4, 07.2018, p. 981-983.

Research output: Contribution to journal › Letter

TY - JOUR

T1 - Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes

T2 - The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation

AU - Usui, Ryota

AU - Sakuramachi, Yui

AU - Seino, Yusuke

AU - Murotani, Kenta

AU - Kuwata, Hitoshi

AU - Tatsuoka, Hisato

AU - Hamamoto, Yoshiyuki

AU - Kurose, Takeshi

AU - Seino, Yutaka

AU - Yabe, Daisuke

PY - 2018/7

Y1 - 2018/7

UR - http://www.scopus.com/inward/record.url?scp=85050007955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050007955&partnerID=8YFLogxK

U2 - 10.1111/jdi.12858

DO - 10.1111/jdi.12858

M3 - Letter

C2 - 29974670

AN - SCOPUS:85050007955

VL - 9

SP - 981

EP - 983

JO - Journal of Diabetes Investigation

JF - Journal of Diabetes Investigation

SN - 2040-1116

IS - 4

ER -

Usui R, Sakuramachi Y, Seino Y, Murotani K, Kuwata H, Tatsuoka H et al. Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation. Journal of Diabetes Investigation. 2018 Jul;9(4):981-983. https://doi.org/10.1111/jdi.12858